The amino-terminal region of the luteinizing hormone choriogonadotropin receptor contacts both subunits of human choriogonadotropin II. Photoaffinity labeling

The luteinizing hormone/choriogonadotropin receptor, a seven-transmembrane receptor, is composed of two equal halves, the N-terminal extracellular exodomain and the C-terminal membrane-associated endodomain. Unlike most seven-transmembrane receptors, the exodomain alone is responsible for high affinity hormone binding, whereas signal is generated in the endodomain. These physical separations of hormone-binding and receptor activation sites are attributed to unique mechanisms for hormone binding and receptor activation of this receptor and its subfamily members. However, the precise hormone contact sites in the exodomain are unclear. In the preceding article (Hong, S,, Phang, T,, Ji, I., and Ji, T, H, (1998) J, Biol. Chem, 273, 13835-13840), a region immediately downstream of the N terminus of the exodomain was shown to be crucial for hormone binding. To test if the region interacts with the hormone, human choriogonadotropin (hCG) was photoaffinity-labeled with a peptide mimic corresponding to Gly(18)-Tyr(36) Of the receptor. This peptide mimic specifically photoaffinity-labeled both the alpha- and beta-subunits of hCG:, Interestingly, hCG alpha was preferentially labeled, On the other hand, denatured hCG was not labeled, and a mutant analog of the peptide failed to label hCG, Furthermore, the affinity labeling was UV-dependent and saturable, indicating the specificity of the photoaffinity labeling. Our results indicate that the region of the exodomain interacts with hCG and that the contact points are near both subunits of hCG, Particularly, the alternate residues (Leu(20), Cys(22), and Gly(24)) are crucial for hCG; binding, In addition, the results underscore the fact that there is a crucial hormone contact site outside of the popularly believed primary hormone-binding site that is composed of Leu-rich repeats and is located in the middle of the exodomain, Our observations are crucial for understanding the molecular mechanism through which the initial high affinity hormone binding leads to receptor activation in the endodomain.